The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Premier Miton assets dip; Challenger Energy CFO quits

Fri, 15th Jul 2022 21:26

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Premier Miton Group PLC - London-based asset manager - Total assets under administration closed third quarter at GBP11.31 billion, sliding from GBP12.8 billion three months earlier. Records GBP300 million in net outflows during the quarter. Blames "uncertainty" caused by geopolitical events led to reduction in assets. "Investors remain cautious about committing to new investments, as highlighted by ongoing outflows across UK public equities, and we saw net outflows of GBP300 million in the period. These were primarily from European and UK equity funds, reflecting softer client sentiment. The outflows were partially offset by inflows into our fixed income funds and the Diversified multi-asset funds," Chief Executive Mike O'Shea adds.

----------

Henderson Diversified Income Trust PLC - Janus Henderson managed fixed income-focused fund - Net asset value per share ends April 30 at 79.55 pence each, sliding from 91.87p at the same point a year prior. It recorded an annual dividend of 4.40p, unchanged on the year before. NAV total return in year to April 30 negative 9.0%, underperforming benchmark which returned negative 7.0%.

----------

Infrastructure India PLC - Isle of Man-based closed-ended investment company focused on assets in India - Grants extension to long stop date for Indian Energy Ltd asset sale. Notes IEL holds two wind farm assets within separate special purpose vehicles, Theni and Gadag, which are its only assets. The GBP5.8 million sale to AVSR Constructions is expected in the coming weeks. It adds: "The company's creditors continue to be supportive, however, should the outstanding conditions not be met by IEL and consequently the sale not proceed, the company will not have adequate funding to meet its liabilities when they fall due and will need to identify other sources of financing."

----------

Warehouse REIT PLC - real estate investment trust focused on warehouses - Draws GBP63.0 million from revolving credit facility with existing lenders to help fund acquisition of Bradwell Abbey Industrial Estate in Milton Keynes. Now has total debt facilities of GBP345.0 million, and facility runs through to January 2025, with an option to extend for a further two years.

----------

Roquefort Therapeutics PLC - London-based biotechnology company - Shares start trading on the OTCQB Venture Market in the US. Notes it will continue to trade on its primary listing, on the Main Market in London. "Cross trading on the OTCQB market allows the company to access one of the world's largest investment markets to expand its reach into a broader pool of investors. Roquefort Therapeutics shares will be available to US investors during US working hours and priced in US dollars and thus has the potential to enable greater liquidity in the company's shares on the London Stock Exchange by easing cross-border trading for potential US investors," it adds.

----------

HealthBeacon PLC - Dublin-based digital therapeutics company developing project for managing injectable medications - Launches new Smart Scale product, which it says is an integrated solution that forms part of its Injection Care Management System. Adds: "The HealthBeacon Smart Scale enables patients to add weight monitoring to its ICMS, as the connected weight scale tracks weight progression, providing clinical teams with insights on specific medication outcomes." Expects Smart Scale will become available to patients this autumn.

----------

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company - In a pre-clinical study of delivery system Nuvec with TNF-alpha, known as Medicines Discovery Catapult, there is clear tumour suppression with 10 micrograms of TNF-alpha loaded into Nuvec, a lower dose than used in earlier studies. Biochemical analysis of blood and tissue samples show that treatment led to an increase in circulating plasma TNF-alpha levels. "We continue to make good progress in understanding how Nuvec can be used in the oncology space," says CEO Nigel Theobald.

----------

Global Invacom Group Ltd - Whitstable, Kent and Singapore-based satellite communications equipment and electronics firm - Says wholly-owned subsidiary Global Invacom Manufacturing (Shanghai) Co Ltd is now dissolved. "The dissolution does not have any material impact on the consolidated net tangible assets per share or earnings per share of the group for the financial year ending December 31, 2022," it adds.

----------

Crossword Cybersecurity PLC - Richmond, England-based cybersecurity solutions company - Issues GBP550,000 of convertible loan notes, with expiry date of July 2025, at a price of 26.1 pence. Notes outstanding loan notes now valued at GBP1.9 million, with GBP225,000 to be repaid in December 2022 and January 2023. Chief Executive Tom Ilube says: "It is pleasing that Crossword is being supported in strengthening its working capital with the extension of current convertible loan notes and issue of additional convertible loan notes with new investors in Crossword."

----------

Doric Nimrod Air One Ltd - Guernsey-based investment company that leases aircraft - Reaches agreement to sell aircraft to Emirates airlines at end of lease, expected to be December 16, for GBP25.3 million. Will distribute sale proceeds to shareholders. "It is currently anticipated that the process for liquidation of the company will commence as soon as practicably possible thereafter, following payment of monies to shareholders," it adds. Liquidation expected in early in the first calendar quarter of 2023. Shareholder return to be about 66 pence.

----------

Mineral & Financial Investments Ltd - Cayman Islands-based investment company - Grants extension to the terms of the earn-in and call option agreements with Ascendant Resources Inc for a 50% interest in Redcorp Empreendimentos Mineros. Ascendant has the option to earn an additional 30% interest in Redcorp, for a total 80% interest. Ascendant now has to complete feasibility study on Lagoa Salgada by June 2023, as well as make a final payment to firm of USD2.5 million. Ascendant expects to complete the study by 1Q 2023.

----------

TomCo Energy PLC - London-based oil explorer in the US state of Utah - Wholly-owned subsidiary, Greenfield Energy LLC, awarded 10-year marginal tax reduction for planned Tar Sands site located in the Uinta Basin, Utah. Says tax reduction could results in savings of up to USD76.3 million. Company can buy up to 90% of Tar Sands site before end of 2022. "We believe our proposed development project in Uintah County is based on an exceptional deposit with tremendous potential. We continue to make good progress with our plans for the TSHII site and continue to advance the previously announced due diligence exercise being undertaken by a potential financing party currently interested in backing our plans for Greenfield," Chief Executive John Potter says.

----------

Challenger Energy Group PLC - Isle of Man-based oil and gas company focused on the Caribbean and the Atlantic-margin - Timothy Eastmond resigns as chief financial officer, effective immediately, for personal reasons. Current Chief Commercial Officer Gagan Khurana to take over CFO role on interim basis, until a suitable permanent replacement is found. Notes Eastmond's 160 million share options under executive option plan to cancel as he has not met performance criteria for the vesting.

----------

Curzon Energy PLC - investor and developer in US based natural gas projects - Continues discussions with Poseidon Enhanced Technologies over potential reverse takeover. Wants to extend exclusivity rights to September 30. "While there can be no certainty at present that these rights will be formally extended, the Company believes that productive discourse continues and will update the markets with any outcome of these discussions in due course," company adds.

----------

Ironveld PLC - South Africa-focused exploration and development company - Raises GBP500,000 from broker option in recent equity raise. Granted Turner Pope Investments ability to buy up to GBP1.0 million in shares in broker option alongside placing. Gross proceeds from placing, as a result, now GBP4.5 million. Says net proceeds will be used to complete the acquisition of FCF and the refurbishment of its existing smelter located in Rustenburg, South Africa.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2024 11:56

N4 Pharma strikes partnership deal for intracellular delivery

(Alliance News) - N4 Pharma PLC on Thursday said it has entered into a collaboration agreement with SRI International Inc.

Read more
23 Apr 2024 13:32

IN BRIEF: N4 Pharma loss widens but "great optimism" remains

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company focused on the development of Nuvec - Posts revenue of GBP1,953 in 2023, compared to no revenue a year ago. Pretax loss widens to GBP1.4 million from GBP1.2 million. Looks ahead to the rest of 2024 with "great optimism."

Read more
18 Apr 2024 12:14

N4 Pharma sees potential in Nuvec delivery method for cancer treatment

(Alliance News) - N4 Pharma PLC on Thursday reported that its novel delivery system for cancer treatment has shown promise, after a successful trial.

Read more
15 Feb 2024 13:17

N4 Pharma shares jump on latest Nuvec developments

(Sharecast News) - N4 Pharma announced a significant advancement in the development of Nuvec, an innovative delivery system tailored for cancer treatments, gene therapy, and vaccines, on Thursday.

Read more
15 Feb 2024 12:06

IN BRIEF: N4 Pharma shares rise on "encouraging" Nuvec research

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company, focused on the development of Nuvec - Reports an "encouraging" update from its Nuvec delivery system for cancer treatments, gene therapy and vaccines. It has completed in-vitro experiments combining epidermal growth factor receptor and polo like kinase 1 molecules onto a Nuvec nanoparticle, before testing it on lung cancer cells. "The work clearly shows that there is a strong beneficial effect at 48 hours on cellular inhibition compared to single dose siRNA, by combining both EGFR and PLK1 onto the same particle," N4 says.

Read more
15 Feb 2024 10:52

AIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A markets

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
19 Jan 2024 13:00

N4 Pharma's Nuvec granted patent in India

(Sharecast News) - N4 Pharma, a pharmaceutical company developing the cancer vaccine delivery system Nuvec, announced on Friday that it has received confirmation from the University of Queensland regarding the granting of its patent for Nuvec in India.

Read more
19 Jan 2024 09:26

IN BRIEF: N4 Pharma gets India patent for medical delivery system

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company, focused on the development of Nuvec - University of Queensland has informed the company that it has been notified by its Indian patent attorney of the granting of its patent for Nuvec in India. Nuvec is a novel silica nanoparticle delivery system for cancer treatments, gene therapy and vaccines. N4 Pharma says the granted patent in India is for a composition of matter patent for the particle itself, alongside the manufacturing process relating to how the particle is made. Says it matches the patents granted in the US, Canada, Europe, Japan, Australia and China.

Read more
16 Jan 2024 14:05

N4 Pharma subsidiary agrees work programme for glaucoma treatment

(Sharecast News) - N4 Pharma announced a significant development through its subsidiary Nanogenics on Tuesday, after Nanogenics inked a contract to initiate the formulation and sequence selection work for its ECP105 product, aimed at pre-clinical studies at King's College, London.

Read more
16 Jan 2024 13:26

IN BRIEF: N4 Pharma touts contract to test glaucoma treatment, ECP105

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company, focused on the development of Nuvec, a novel silica nanoparticle delivery system, for vaccines and therapeutics - Says subsidiary, Nanogenics Ltd, has signed a contract to start the formulation and sequence selection work to prepare its ECP105 product for testing in pre-clinical studies at King's College, London.

Read more
8 Jan 2024 12:30

N4 Pharma reports progress in Nuvec clinical research

(Sharecast News) - Pharmaceutical delivery system developer N4 Pharma reported significant progress in its research efforts to enhance viral vector performance using Nuvec on Monday.

Read more
8 Jan 2024 09:11

N4 Pharma hails increased efficacy of Nuvec when complexed with AAV8

(Alliance News) - N4 Pharma PLC on Monday said that a series of experiments have shown that Nuvec can deliver increased transduction efficacy, when complexed with Adeno-Associated virus 8.

Read more
18 Dec 2023 16:55

LONDON MARKET CLOSE: FTSE 100 outperforms European peers

(Alliance News) - Stock prices in London closed higher on Monday, after investors shrugged off hawkish comments from US Federal Reserve officials amid festive cheer.

Read more
18 Dec 2023 12:43

N4 Pharma rises on successful results from Nuvec administration

(Alliance News) - N4 Pharma PLC on Monday announced the successful oral administration of Nuvec with a DNA plasmid after receiving promising results from its research programme with the University of Queensland.

Read more
18 Dec 2023 11:17

N4 Pharma upbeat on recent Nuvec developments

(Sharecast News) - N4 Pharma updated the market on Monday on its ongoing research efforts related to Nuvec, its delivery system designed for cancer treatments and vaccines.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.